Healthcare

Drug Device Combination Products Market Sales & Trends

The Single-Chamber Prefilled Syringes Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Single-Chamber Prefilled Syringes Market:

https://www.thebusinessresearchcompany.com/report/single-chamber-prefilled-syringes-global-market-report

According to The Business Research Company’s Single-Chamber Prefilled Syringes Global Market Report 2024, The single-chamber prefilled syringes market size has grown rapidly in recent years. It will grow from $9.74 billion in 2023 to $11 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to growth in pharmaceutical and biotechnology sectors, patient-friendly drug administration, safety and ease of use, demand for precise drug dosing, regulatory approvals and guidelines..

The single-chamber prefilled syringes market size is expected to see rapid growth in the next few years. It will grow to $19.22 billion in 2028 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to biologics and biosimilars in prefilled syringes, self-administration and home healthcare, pediatric and geriatric drug delivery, combination products with auto-injectors, regulatory emphasis on drug safety, telemedicine and remote monitoring.. Major trends in the forecast period include prefilled syringes with connected devices, sustainable and biodegradable materials, customized and patient-specific syringe options, needlestick prevention and safety features, prefilled syringes for cell and gene therapies, prefilled syringes with anti-counterfeiting measures..

The growing prevalence of chronic diseases such as diabetes and cancer are contributing to the growth of the single-chamber prefilled syringe market. Diabetes patients who require insulin therapy when medicines cannot control their blood glucose levels use the single-chamber prefilled syringe. According to the IDF Diabetes Atlas 2021, an organization that promotes diabetes care, prevention, and a cure worldwide, 1 in 10 individuals (20–79 years old) have diabetes, which affects 537 million people. By 2030, this figure is expected to reach 643 million, and by 2045, it will reach 783 million. According to the American Cancer Society, in 2021, 1.9 million new cancer cases will be registered. Therefore, the growing prevalence of chronic diseases such as diabetes and cancer drives the market for single-chamber prefilled syringes.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=5419&type=smp

The single-chamber prefilled syringes market covered in this report is segmented –

1) By Type: Glass, Plastic

2) By Application: Vaccine Product, Biologic, Pharmaceutical Product

Growing technological advancements are shaping the single-chamber prefilled syringe market. Major companies operating in the single-chamber prefilled syringe sector are focused on developing technological solutions for the single-chamber prefilled syringe market to strengthen their position. For instance, in September 2022, Otsuka America Pharmaceutical, Inc., a US-based healthcare company, and H. Lundbeck A/S, a Danish international pharmaceutical company, introduced Aripiprazole 2-month. It comes in a single-chamber, prefilled syringe and is a 2-month, ready-to-use, long-acting injectable form of aripiprazole. The gluteal muscle is where it is to be injected intramuscularly every two months for the dosage.

The single-chamber prefilled syringes market report table of contents includes: